Ewon Comfortech to Acquire Additional Liminatus Pharma Shares for 3.9 Billion KRW
Ewon Comfortech, a company specializing in automotive seats and listed on KOSDAQ, announced on January 2 that it will acquire an additional 4,373,603 shares of the bio-pharmaceutical company Liminatus Pharma for approximately 3.9 billion KRW.
After the share acquisition, its ownership stake will increase to 20.68%. The scheduled date for the share acquisition is December 31, 2025.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
Ewon Comfortech explained that the purpose of this share acquisition is "to secure liquidity for shares issued by overseas companies held by the company and to enhance the value of its shares."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.